Dr. Malloy graduated from Dartmouth College in 1972, and served as a Navy officer for the next four years. He earned a PhD in clinical psychology from SUNY Binghamton in 1981. He has been on the Brown Faculty since 1983. He served as Director of Psychology at Butler Hospital and Co-Director of the Memory and Aging Program at Butler Hospital until 2019. He coordinated the Neuropsychology Track of the Brown Clinical Psychology Training Consortium for many years.
| O'Shea, Deirdre M., Thomas, Kelsey R., Asken, Breton, Lee, Athene K.W., Davis, Jennifer D., Malloy, Paul F., Salloway, Stephen P., Correia, Stephen, None, None. "Adding cognition to AT(N) models improves prediction of cognitive and functional decline." Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, vol. 13, no. 1, 2021. |
| Niermeyer M, Gaudet C, Malloy P, Piryatinsky I, Salloway S, Klinge P, Lee A. "Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status." Journal of the International Neuropsychological Society, vol. 26, no. 9, 2020, pp. 1-11. |
| Bruchhage MMK, Correia S, Malloy P, Salloway S, Deoni S. "Machine Learning Classification Identifies Cerebellar Contributions to Early and Moderate Cognitive Decline in Alzheimer's Disease." Frontiers in Aging Neuroscience, vol. 12, 2020, pp. 524024. |
| Castelluccio, Brian C., Malloy, Paul F., McLaughlin, Nicole C.R. "Neuropsychological features of delusions in hospitalized older adults with neurocognitive disorders." Journal of Clinical and Experimental Neuropsychology, vol. 42, no. 9, 2020, pp. 941-951. |
| Asken BM, Thomas KR, Lee A, Davis JD, Malloy PF, Salloway SP, Correia S. "Discrepancy-Based Evidence for Loss of Thinking Abilities (DELTA): Development and Validation of a Novel Approach to Identifying Cognitive Changes." Journal of the International Neuropsychological Society, vol. 26, no. 5, 2019, pp. 464-479. |
| Alsemari, Ahmad, Malloy, Paul F. "The behavioral dyscontrol scale in the differential diagnosis of behavioral variant of frontotemporal dementia and Alzheimer disease." The Clinical Neuropsychologist, 2019, pp. 1-10. |
| Chapman KR, Tremont G, Malloy P, Spitznagel MB. "The Role of Sexual Disinhibition to Predict Caregiver Burden and Desire to Institutionalize Among Family Dementia Caregivers." Journal of Geriatric Psychiatry and Neurology, 2019, pp. 891988719856688. |
| Rossetti MA, Piryatinsky I, Ahmed FS, Klinge PM, Relkin NR, Salloway S, Ravdin LD, Brenner E, Malloy PF, Levin BE, Broggi M, Gavett R, Maniscalco JS, Katzen H. "Two Novel Psychomotor Tasks in Idiopathic Normal Pressure Hydrocephalus." Journal of the International Neuropsychological Society, vol. 22, no. 3, 2016, pp. 341-9. |
| Correia S, Ahern DC, Rabinowitz AR, Farrer TJ, Smith Watts AK, Salloway S, Malloy PF, Deoni SC. "Lowering the Floor on Trail Making Test Part B: Psychometric Evidence for a New Scoring Metric." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 30, no. 7, 2015, pp. 643-56. |
| Bryant, Vaughn E., Whitehead, Nicole E., Burrell, Larry E., Dotson, Vonetta M., Cook, Robert L., Malloy, Paul, Devlin, Kathryn, Cohen, Ronald A. "Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders." AIDS and Behavior, vol. 19, no. 8, 2014, pp. 1430-1437. |
| Carvalho JO, Ready RE, Malloy P, Grace J. "Confirmatory Factor Analysis of the Frontal Systems Behavior Scale (FrSBe)." Assessment, vol. 20, no. 5, 2013, pp. 632-641. |
| Lee, Athene, Rao, Julia, van Huiden, Steven, Correia, Stephen, O'Muircheartaigh, Jonathan, Deoni, Sean, Salloway, Stephen, Malloy, Paul. "Myelin integrity, cognitive function and hypertension in MCI and Alzheimer's disease." Alzheimer's & Dementia, vol. 9, no. 4, 2013, pp. P275-P276. |
| Lee, Athene, Rao, Julia, van Huiden, Steven, Correia, Stephen, O'Muircheartaigh, Jonathan, Deoni, Sean, Salloway, Stephen, Malloy, Paul. "Myelin integrity, cognitive function and hypertension in MCI and Alzheimer’s disease." Alzheimer's & Dementia, vol. 9, no. 4, 2013, pp. P103. |
| Kubu CS, Malone DA, Chelune G, Malloy P, Rezai AR, Frazier T, Machado A, Rasmussen S, Friehs G, Greenberg BD. "Neuropsychological outcome after deep brain stimulation in the ventral capsule/ventral striatum for highly refractory obsessive-compulsive disorder or major depression." Stereotactic and functional neurosurgery, vol. 91, no. 6, 2013, pp. 374-378. |
| Klinge, Petra, Malloy, Paul, Salloway, Stephen, Blennow, Kaj. "Outcome of shunt surgery for normal pressure hydrocephalus in patients with and without comorbid Alzheimer's disease." Alzheimer's & Dementia, vol. 9, no. 4, 2013, pp. P850. |
| Mikos, Ania E., Piryatinsky, Irene, Tremont, Geoffrey, Malloy, Paul F. "The APOE ε4 Allele Is Associated With Increased Frontally Mediated Neurobehavioral Symptoms in Amnestic MCI." Alzheimer Disease & Associated Disorders, vol. 27, no. 2, 2013, pp. 109-115. |
| Frakey, Laura L., Salloway, Stephen, Buelow, Melissa, Malloy, Paul. "A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for the Treatment of Apathy in Individuals With Mild-to-Moderate Alzheimer’s Disease." J. Clin. Psychiatry, vol. 73, no. 06, 2012, pp. 796-801. |
| Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM, Alzheimer's Disease Neuroimaging Initiative., Pediatric Imaging, Neurocognition, and Genetics Study., Weiner M, Aisen P, Petersen R, Jack CR Jr, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Ging-Yuek, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, Olichney J, Kittur S, Borrie M, Lee TY, Bartha R, Johnson S, Asthana S, Carlsson CM, Potkin SG, Preda A, Nguyen D, Tariot P, Fleisher A, Reeder S, Bates V, Capote H, Rainka M, Scharre DW, Kataki M, Zimmerman EA, Celmins D, Brown AD, Pearlson GD, Blank K, Anderson K, Santulli RB, Schwartz ES, Sink KM, Williamson JD, Garg P, Watkins F, Ott BR, Querfurth H, Tremont G, Salloway S, Malloy P, Correia S, Rosen HJ, Miller BL, Mintzer J, Longmire CF, Spicer K, Finger E, Rachinsky I, Drost D, Jernigan T, McCabe C, Grant E, Ernst T, Kuperman J, Chung Y, Murray S, Bloss C, Darst B, Pritchett L, Saito A, Amaral D, DiNino M, Eyngorina B, Sowell E, Houston S, Soderberg L, Kaufmann W, van Zijl P, Rizzo-Busack H, Javid M, Mehta N, Ruberry E, Powers A, Rosen B, Gebhard N, Manigan H, Frazier J, Kennedy D, Yakutis L, Hill M, Gruen J, Bosson-Heenan J, Carlson H. "Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans." Proceedings of the National Academy of Sciences, vol. 109, no. 10, 2012, pp. 3985-90. |
| McLaughlin NC, Chang AC, Malloy P. "Verbal and Nonverbal Learning and Recall in Dementia with Lewy Bodies and Alzheimer's Disease." Applied Neuropsychology, vol. 19, no. 2, 2012, pp. 86-89. |
| Correia, Stephen, Rabinowitz, Amanda, Ahern, David, D'Angelo, Christina, Salloway, Stephen, Malloy, Paul, Deoni, Sean. "White matter correlates of a new scoring metric for Trail-Making Test B." Alzheimer's & Dementia, vol. 8, no. 4, 2012, pp. P59. |
| Correia, Stephen, Rabinowitz, Amanda, Ahern, David, Malloy, Paul, Salloway, Stephen, Deoni, Sean. "White matter correlates of a new scoring metric for trail-making test-B." Alzheimer's & Dementia, vol. 8, no. 4, 2012, pp. P555-P556. |
| Deoni, Sean, Correia, Steve, Su, Tanja, Man, Jessica, Lehman, Katie, Malloy, Paul, Salloway, Stephen. "Investigating limbic system myelin alteration in Alzheimer's disease." Alzheimer's & Dementia, vol. 7, no. 4, 2011, pp. S57-S58. |
| Deoni, Sean, Correia, Steve, Tanja, Su, Man, Jessica, Katie, Lehman, Malloy, Paul, Salloway, Stephen. "Investigating limbic system myelin alteration in Alzheimer's disease." Alzheimer's & Dementia, vol. 7, no. 4, 2011, pp. S715. |
| Deoni, Sean, Correia, Steve, Su, Tanja, Man, Jessica, Lehman, Katie, Malloy, Paul, Salloway, Stephen. "Investigating white matter myelin content across the spectrum of Alzheimer's disease." Alzheimer's & Dementia, vol. 7, no. 4, 2011, pp. S58. |
| Deoni, Sean, Correia, Steve, Su, Tanja, Man, Jessica, Lehman, Katie, Malloy, Paul, Salloway, Stephen. "Investigating white matter myelin content across the spectrum of Alzheimer's disease." Alzheimer's & Dementia, vol. 7, no. 4, 2011, pp. S715-S716. |
| Wolk, D. A., Dickerson, B. C., Weiner, M., Aiello, M., Aisen, P., Albert, M. S., Alexander, G., Anderson, H. S., Anderson, K., Apostolova, L., Arnold, S., Ashford, W., Assaly, M., Asthana, S., Bandy, D., Bartha, R., Bates, V., Beckett, L., Bell, K. L., Benincasa, A. L., Bergman, H., Bernick, C., Bernstein, M., Black, S., Blank, K., Borrie, M., Brand, C., Brewer, J., Brown, A. D., Burns, J. M., Cairns, N. J., Caldwell, C., Capote, H., Carlsson, C. M., Carmichael, O., Cellar, J. S., Celmins, D., Chen, K., Chertkow, H., Chowdhury, M., Clark, D., Connor, D., Correia, S., Crawford, K., Dale, A., de Leon, M. J., De Santi, S. M., DeCarli, C., deToledo-Morrell, L., DeVous, M., Diaz-Arrastia, R., Dolen, S., Donohue, M., Doody, R. S., Doraiswamy, P. M., Duara, R., Englert, J., Farlow, M., Feldman, H., Felmlee, J., Fleisher, A., Fletcher, E., Foroud, T. M., Foster, N., Fox, N., Frank, R., Gamst, A., Given, C. A., Graff-Radford, N. R., Green, R. C., Griffith, R., Grossman, H., Hake, A. M., Hardy, P., Harvey, D., Heidebrink, J. L., Hendin, B. A., Herring, S., Honig, L. S., Hosein, C., Robin Hsiung, G.-Y., Hudson, L., Ismail, M. S., Jack, C. R., Jacobson, S., Jagust, W., Jayam-Trouth, A., Johnson, K., Johnson, H., Johnson, N., Johnson, K., Johnson, K. A., Johnson, S., Kachaturian, Z., Karlawish, J. H., Kataki, M., Kaye, J., Kertesz, A., Killiany, R., Kittur, S., Koeppe, R. A., Korecka, M., Kornak, J., Kozauer, N., Lah, J. J., Laubinger, M. M., Lee, V. M.- Y., Lee, T.- Y., Lerner, A., Levey, A. I., Longmire, C. F., Lopez, O. L., Lord, J. L., Lu, P. H., MacAvoy, M. G., Malloy, P., Marson, D., Martin-Cook, K., Martinez, W., Marzloff, G., Mathis, C., Mc-Adams-Ortiz, C., Mesulam, M., Miller, B. L., Mintun, M. A., Mintzer, J., Molchan, S., Montine, T., Morris, J., Mulnard, R. A., Munic, D., Nair, A., Neu, S., Nguyen, D., Norbash, A., Oakley, M., Obisesan, T. O., Ogrocki, P., Ott, B. R., Parfitt, F., Pawluczyk, S., Pearlson, G., Petersen, R., Petrella, J. R., Potkin, S., Potter, W. Z., Preda, A., Quinn, J., Rainka, M., Reeder, S., Reiman, E. M., Rentz, D. M., Reynolds, B., Richard, J., Roberts, P., Rogers, J., Rosen, A., Rosen, H. J., Rusinek, H., Sabbagh, M., Sadowsky, C., Salloway, S., Santulli, R. B., Saykin, A. J., Scharre, D. W., Schneider, L., Schneider, S., Schuff, N., Shah, R. C., Shaw, L., Shen, L., Silverman, D. H. S., Simpson, D. M., Sink, K. M., Smith, C. D., Snyder, P. J., Spann, B. M., Sperling, R. A., Spicer, K., Stefanovic, B., Stern, Y., Stopa, E., Tang, C., Tariot, P., Taylor-Reinwald, L., Thai, G., Thomas, R. G., Thompson, P., Tinklenberg, J., Toga, A. W., Tremont, G., Trojanowki, J. Q., Trost, D., Turner, R. S., van Dyck, C. H., Vanderswag, H., Varon, D., Villanueva-Meyer, J., Villena, T., Walter, S., Wang, P., Watkins, F., Weiner, M., Williamson, J. D., Wolk, D., Wu, C.-K., Zerrate, M., Zimmerman., E. A. "Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease." Proceedings of the National Academy of Sciences, vol. 107, no. 22, 2010, pp. 10256-10261. |
| Malloy, Paul, McLaughlin, Nicole C. R., Epstein-Lubow, Gary, Doughty, Anne, Marino, Louis, Milner, Marnee. "The Severe Impairment Battery Predicts Functional Abilities in an Inpatient Geriatric Population." Applied Neuropsychology, vol. 17, no. 3, 2010, pp. 172-6. |
| Malone, Donald A., Dougherty, Darin D., Rezai, Ali R., Carpenter, Linda L., Friehs, Gerhard M., Eskandar, Emad N., Rauch, Scott L., Rasmussen, Steven A., Machado, Andre G., Kubu, Cynthia S., Tyrka, Audrey R., Price, Lawrence H., Stypulkowski, Paul H., Giftakis, Jonathon E., Rise, Mark T., Malloy, Paul F., Salloway, Stephen P., Greenberg, Benjamin D. "Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression." Biological Psychiatry, vol. 65, no. 4, 2009, pp. 267-275. |
| Greenberg, B D, Gabriels, L A, Malone, D A, Rezai, A R, Friehs, G M, Okun, M S, Shapira, N A, Foote, K D, Cosyns, P R, Kubu, C S, Malloy, P F, Salloway, S P, Giftakis, J E, Rise, M T, Machado, A G, Baker, K B, Stypulkowski, P H, Goodman, W K, Rasmussen, S A, Nuttin, B J. "Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience." Molecular Psychiatry, vol. 15, no. 1, 2008, pp. 64-79. |
| Correia S, Lee SY, Voorn T, Tate DF, Paul RH, Zhang S, Salloway SP, Malloy PF, Laidlaw DH. "Quantitative tractography metrics of white matter integrity in diffusion-tensor MRI." NeuroImage, vol. 42, no. 2, 2008, pp. 568-581. |
| Williams VG, Bruce JM, Westervelt HJ, Davis JD, Grace J, Malloy PF, Tremont G. "Boston naming performance distinguishes between Lewy body and Alzheimer's dementias." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 22, no. 8, 2007, pp. 925-931. |
| Grant, Jon E., Correia, Stephen, Brennan-Krohn, Thea, Malloy, Paul F., Laidlaw, David H., Schulz, S. Charles. "Frontal White Matter Integrity in Borderline Personality Disorder With Self-Injurious Behavior." The Journal of neuropsychiatry and clinical neurosciences, vol. 19, no. 4, 2007, pp. 383-390. |
| Grant, Jon E., Correia, Stephen, Brennan-Krohn, Thea, Malloy, Paul F., Laidlaw, David H., Schulz, S. Charles. "Frontal White Matter Integrity in Borderline Personality Disorder With Self-Injurious Behavior." The Journal of neuropsychiatry and clinical neurosciences, vol. 19, no. 4, 2007, pp. 383-390. |
| Malloy, Paul, Correia, Stephen, Stebbins, Glenn, Laidlaw, David H. "Neuroimaging of White Matter in Aging and Dementia." The Clinical Neuropsychologist, vol. 21, no. 1, 2007, pp. 73-109. |
| Royall, Donald R., Lauterbach, Edward C., Kaufer, Daniel, Malloy, Paul, Coburn, Kerry L., Black, Kevin J. "The Cognitive Correlates of Functional Status: A Review From the Committee on Research of the American Neuropsychiatric Association." JNP, vol. 19, no. 3, 2007, pp. 249-265. |
| Royall, Donald R., Lauterbach, Edward C., Kaufer, Daniel, Malloy, Paul, Coburn, Kerry L., Black, Kevin J. "The Cognitive Correlates of Functional Status: A Review From the Committee on Research of the American Neuropsychiatric Association." The Journal of neuropsychiatry and clinical neurosciences, vol. 19, no. 3, 2007, pp. 249-265. |
| Malloy P, Tremont G, Grace J, Frakey L. "The Frontal Systems Behavior Scale discriminates frontotemporal dementia from Alzheimer’s disease." Alzheimer's & Dementia, vol. 3, no. 3, 2007, pp. 200-3. |
| Correia, Stephen, Lee, Stephanie Y., Zhang, Song, Salloway, Stephen P., Malloy, Paul F., Laidlaw, David H. "IC-P-083." Alzheimer's & Dementia, vol. 2, no. 3, 2006, pp. S686. |
| Correia, Stephen, Lee, Stephanie Y., Zhang, Song, Salloway, Stephen P., Malloy, Paul F., Laidlaw, David H. "P2-270." Alzheimer's & Dementia, vol. 2, no. 3, 2006, pp. S317-S318.2. |
| Greenberg, Benjamin D, Malone, Donald A, Friehs, Gerhard M, Rezai, Ali R, Kubu, Cynthia S, Malloy, Paul F, Salloway, Stephen P, Okun, Michael S, Goodman, Wayne K, Rasmussen, Steven A. "Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder." Neuropsychopharmacology, vol. 31, no. 11, 2006, pp. 2384-93. |
| Jones, Richard N., Rosenberg, Adrienne L., Morris, John N., Allaire, Jason C., McCoy, Karin J. M., Marsiske, Michael, Kleinman, Ken P., Rebok, George W., Malloy, Paul F. "A Growth Curve Model of Learning Acquisition among Cognitively Normal Older Adults." Experimental aging research, vol. 31, no. 3, 2005, pp. 291-312. |
| Malloy, Paul, Grace, Janet. "A Review of Rating Scales for Measuring Behavior Change Due to Frontal Systems Damage." Cognitive and Behavioral Neurology, vol. 18, no. 1, 2005, pp. 18-27. |
| Malloy P, Grace J. "A review of rating scales for measuring behavior change due to frontal systems damage." Cognitive and Behavioral Neurology, vol. 18, no. 1, 2005, pp. 18-27. |
| Paul, Robert H., Brickman, Adam M., Navia, Bradford, Hinkin, Charles, Malloy, Paul F., Jefferson, Angela L., Cohen, Ronald A., Tate, David F., Flanigan, Timothy P. "Apathy is associated with volume of the nucleus accumbens in patients infected with HIV." The Journal of neuropsychiatry and clinical neurosciences, vol. 17, no. 2, 2005, pp. 167-71. |
| BELANGER, H, WILDERWILLIS, K, MALLOY, P, SALLOWAY, S, HAMMAN, R, GRIGSBY, J. "Assessing motor and cognitive regulation in AD, MCI, and controls using the Behavioral Dyscontrol Scale." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 20, no. 2, 2005, pp. 183-189. |
| Friend, Karen B., Malloy, Paul F., Sindelar, Holly A. "The effects of chronic nicotine and alcohol use on neurocognitive function." Addictive Behaviors, vol. 30, no. 1, 2005, pp. 193-202. |
| Davis Garrett, Kelly, Cohen, Ronald A., Paul, Robert H., Moser, David J., Malloy, Paul F., Shah, Pari, Haque, Omar. "Computer-Mediated Measurement and Subjective Ratings of White Matter Hyperintensities in Vascular Dementia: Relationships to Neuropsychological Performance." The Clinical Neuropsychologist, vol. 18, no. 1, 2004, pp. 50-62. |
| Malloy, Paul F., Belanger, Heather, Hall, Stuart, Grigsby, Jim, Hamman, Richard F., Wilder-Willis, Kelly, Aloia, Mark, Salloway, Stephen. "P1-061 Validation of measures of spatial and executive abilities in Alzheimer's disease and mild cognitive impairment." Neurobiology of Aging, vol. 25, 2004, pp. S112. |
| Correia, Stephen, Salloway, Stephen, Malloy, Paul, Song, Christopher, Li, Ryan. "P2-182 Systolic blood pressure variability and subcortical hyperintensities in patients with mild-to-moderate Alzheimer's disease." Neurobiology of Aging, vol. 25, 2004, pp. S278-S279. |
| Correia, Stephen, Zhang, Song, Laidlaw, David, Malloy, Paul, Salloway, Stephen. "P2-232 Diffusion-tensor imaging: linear, planar, and spherical diffusion in cadasil." Neurobiology of Aging, vol. 25, 2004, pp. S298. |
| Boyle, Patricia A., Malloy, Paul F. "Treating Apathy in Alzheimer’s Disease." Dementia and Geriatric Cognitive Disorders, vol. 17, no. 1-2, 2004, pp. 91-99. |
| Malloy P, Belanger H, Hall S, Aloia M, Salloway S. "Assessing visuoconstructional performance in AD, MCI and normal elderly using the Beery Visual-Motor Integration Test." The Clinical Neuropsychologist, vol. 17, no. 4, 2003, pp. 544-550. |
| Paul RH, Cohen RA, Moser DJ, Ott BR, Sethi M, Sweet L, Browndyke J, Malloy P, Garrett K. "Clinical correlates of cognitive decline in vascular dementia." Cognitive and Behavioral Neurology, vol. 16, no. 1, 2003, pp. 40-6. |
| Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL. "Executive dysfunction and apathy predict functional impairment in Alzheimer disease." The American Journal of Geriatric Psychiatry, vol. 11, no. 2, 2003, pp. 214-21. |
| Stout JC, Ready RE, Grace J, Malloy PF, Paulsen JS. "Factor analysis of the frontal systems behavior scale (FrSBe)." Assessment, vol. 10, no. 1, 2003, pp. 79-85. |
| Cahn-Weiner DA, Ready RE, Malloy PF. "Neuropsychological predictors of everyday memory and everyday functioning in patients with mild Alzheimer's disease." Journal of Geriatric Psychiatry and Neurology, vol. 16, no. 2, 2003, pp. 84-9. |
| Cahn-Weiner DA, Malloy PF, Rebok GW, Ott BR. "Results of a randomized placebo-controlled study of memory training for mildly impaired Alzheimer's disease patients." Applied Neuropsychology, vol. 10, no. 4, 2003, pp. 215-23. |
| Rymer S, Salloway S, Norton L, Malloy P, Correia S, Monast D. "Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer disease." Alzheimer Disease & Associated Disorders, vol. 16, no. 4, 2002, pp. 248-53. |
| Salloway S, Correia S, Boyle P, Malloy P, Schneider L, Lavretsky H, Sackheim H, Roose S, Krishnan KR. "MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression." Journal of the Neurological Sciences, vol. 203-204, 2002, pp. 227-33. |
| Cahn-Weiner DA, Boyle PA, Malloy PF. "Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals." Applied Neuropsychology, vol. 9, no. 3, 2002, pp. 187-91. |
| Salloway S, Boyle PA, Correia S, Malloy PF, Cahn-Weiner DA, Schneider L, Krishnan KR, Nakra R. "The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients." The American Journal of Geriatric Psychiatry, vol. 10, no. 1, 2002, pp. 107-11. |
| Norton LE, Malloy PF, Salloway S. "The impact of behavioral symptoms on activities of daily living in patients with dementia." The American Journal of Geriatric Psychiatry, vol. 9, no. 1, 2001, pp. 41-8. |
| Paul RH, Piatt AL, Whelihan WM, Malloy PF. "Neuropsychological and magnetic resonance imaging abnormalities associated with a plasmacytoma of the frontal dura: a case report." Neuropsychiatry, neuropsychology, and behavioral neurology, vol. 13, no. 2, 2000, pp. 143-7. |
| Cahn-Weiner, Deborah A., Malloy, Paul F., Boyle, Patricia A., Marran, Mary, Salloway, Stephen. "Prediction of Functional Status from Neuropsychological Tests in Community-Dwelling Elderly Individuals." The Clinical Neuropsychologist, vol. 14, no. 2, 2000, pp. 187-195. |
| Cahn-Weiner DA, Malloy PF, Boyle PA, Marran M, Salloway S. "Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals." The Clinical Neuropsychologist, vol. 14, no. 2, 2000, pp. 187-95. |
| Grace J, Stout JC, Malloy PF. "Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale." Assessment, vol. 6, no. 3, 1999, pp. 269-84. |
| Jenkins M, Malloy P, Salloway S, Cohen R, Rogg J, Tung G, Kohn R, Westlake R, Johnson EG, Richardson E. "Memory processes in depressed geriatric patients with and without subcortical hyperintensities on MRI." Journal of Neuroimaging, vol. 8, no. 1, 1998, pp. 20-6. |
| Lauterbach EC, Cummings JL, Duffy J, Coffey CE, Kaufer D, Lovell M, Malloy P, Reeve A, Royall DR, Rummans TA, Salloway SP. "Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association." The Journal of neuropsychiatry and clinical neurosciences, vol. 10, no. 3, 1998, pp. 249-66. |
| Jenkins, Melissa, Cohen, Ronald, Malloy, Paul, Salloway, Stephen, Gillard Johnson, Eileen, Penn, Joseph, Marcotte, Ann. "Neuropsychological Measures which Discriminate Among Adults with Residual Symptoms of Attention Deficit Disorder and Other Attentional Complaints." The Clinical Neuropsychologist, vol. 12, no. 1, 1998, pp. 74-83. |
| Moser DJ, Cohen RA, Malloy PF, Stone WM, Rogg JM. "Reduplicative paramnesia: longitudinal neurobehavioral and neuroimaging analysis." Journal of Geriatric Psychiatry and Neurology, vol. 11, no. 4, 1998, pp. 174-80. |
| Cummings JL, Coffey CE, Duffy JD, Lauterbach EC, Lovell M, Malloy PF, Royall DR, Rummans TA, Salloway S. "The clinician-scientist in neuropsychiatry: a position statement from the Committee on Research of the American Neuropsychiatric Association." The Journal of neuropsychiatry and clinical neurosciences, vol. 10, no. 1, 1998, pp. 1-9. |
| Lukatela K, Malloy P, Jenkins M, Cohen R. "The naming deficit in early Alzheimer's and vascular dementia." Neuropsychology, vol. 12, no. 4, 1998, pp. 565-72. |
| Malloy PF, Cummings JL, Coffey CE, Duffy J, Fink M, Lauterbach EC, Lovell M, Royall D, Salloway S. "Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association." The Journal of neuropsychiatry and clinical neurosciences, vol. 9, no. 2, 1997, pp. 189-97. |
| Jenkins MA, Cimino C, Malloy PF, Salloway S, Cohen R, Kohn R, Westlake R. "Neuropsychiatric factors in the illusion of visitors among geriatric patients: a case series." Journal of Geriatric Psychiatry and Neurology, vol. 10, no. 2, 1997, pp. 79-87. |
| Mega MS, Cummings JL, Salloway S, Malloy P. "The limbic system: an anatomic, phylogenetic, and clinical perspective." The Journal of neuropsychiatry and clinical neurosciences, vol. 9, no. 3, 1997, pp. 315-30. |
| Cloud BS, Carew TG, Rothenberg H, Malloy P, Libon DJ. "A case of late-onset psychosis: integrating neuropsychological and SPECT data." Journal of Geriatric Psychiatry and Neurology, vol. 9, no. 3, 1996, pp. 146-53. |
| Nadler JD, Grace J, White DA, Butters MA, Malloy PF. "Laterality differences in quantitative and qualitative Hooper performance." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 11, no. 3, 1996, pp. 223-9. |
| Salloway S, Malloy P, Kohn R, Gillard E, Duffy J, Rogg J, Tung G, Richardson E, Thomas C, Westlake R. "MRI and neuropsychological differences in early- and late-life-onset geriatric depression." Neurology, vol. 46, no. 6, 1996, pp. 1567-74. |
| Waldstein SR, Malloy PF, Stout R, Longabaugh R. "Predictors of neuropsychological impairment in alcoholics: antisocial versus nonantisocial subtypes." Addictive Behaviors, vol. 21, no. 1, 1996, pp. 21-7. |
| Cahn DA, Malloy PF, Salloway S, Rogg J, Gillard E, Kohn R, Tung G, Richardson ED, Westlake R. "Subcortical hyperintensities on MRI and activities of daily living in geriatric depression." The Journal of neuropsychiatry and clinical neurosciences, vol. 8, no. 4, 1996, pp. 404-11. |
| Coffey CE, Cummings JL, Duffy JD, Fink M, Lauterbach EC, Lovell MR, Malloy P, Nussbaum PD, Royall DR, Salloway S. "Assessment of treatment outcomes in neuropsychiatry: a report from the Committee on Research of the American Neuropsychiatric Association." The Journal of neuropsychiatry and clinical neurosciences, vol. 7, no. 3, 1995, pp. 287-9. |
| Malloy PF, Richardson ED. "Assessment of frontal lobe functions." The Journal of neuropsychiatry and clinical neurosciences, vol. 6, no. 4, 1994, pp. 399-410. |
| Longabaugh R, Rubin A, Malloy P, Beattie M, Clifford PR, Noel N. "Drinking outcomes of alcohol abusers diagnosed as antisocial personality disorder." Alcoholism: Clinical and Experimental Research, vol. 18, no. 4, 1994, pp. 778-85. |
| Duffy JD, Malloy PF. "Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial." Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, vol. 6, no. 1, 1994, pp. 33-7. |
| Malloy PF, Richardson ED. "The frontal lobes and content-specific delusions." The Journal of neuropsychiatry and clinical neurosciences, vol. 6, no. 4, 1994, pp. 455-66. |
| Nadler JD, Richardson ED, Malloy PF, Marran ME, Hosteller Brinson ME. "The ability of the Dementia Rating Scale to predict everyday functioning." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 8, no. 5, 1993, pp. 449-60. |
| Longabaugh R, Beattie M, Noel N, Stout R, Malloy P. "The effect of social investment on treatment outcome." J. Stud. Alcohol, vol. 54, no. 4, 1993, pp. 465-78. |
| Malloy P, Bihrle A, Duffy J, Cimino C. "The orbitomedial frontal syndrome." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 8, no. 3, 1993, pp. 185-201. |
| Solomon DA, Malloy PF. "Alcohol, head injury, and neuropsychological function." Neuropsychology review, vol. 3, no. 3, 1992, pp. 249-80. |
| Richardson ED, Malloy PF, Longabaugh R, Williams J, Noel N, Beattie MC. "Liver function tests and neuropsychologic impairment in substance abusers." Addictive Behaviors, vol. 16, no. 1-2, 1991, pp. 51-5. |
| Richardson ED, Malloy PF, Grace J. "Othello syndrome secondary to right cerebrovascular infarction." Journal of Geriatric Psychiatry and Neurology, vol. 4, no. 3, 1991, pp. 160-5. |
| Malloy P, Noel N, Longabaugh R, Beattie M. "Determinants of neuropsychological impairment in antisocial substance abusers." Addictive Behaviors, vol. 15, no. 5, 1990, pp. 431-8. |
| Malloy P, Mishra SK, Adler SH. "Neuropsychological deficits in myotonic muscular dystrophy." Journal of Neurology, Neurosurgery & Psychiatry, vol. 53, no. 11, 1990, pp. 1011-3. |
| Kohn R, Lilly RB, Sokol MS, Malloy PF. "Psychiatric presentations of intracranial cysts." The Journal of neuropsychiatry and clinical neurosciences, vol. 1, no. 1, 1989, pp. 60-6. |
| Malloy P, Noel N, Rogers S, Longabaugh R, Beattie M. "Risk factors for neuropsychological impairment in alcoholics: antisocial personality, age, years of drinking and gender." J. Stud. Alcohol, vol. 50, no. 5, 1989, pp. 422-6. |
| Malloy P, Rasmussen S, Braden W, Haier RJ. "Topographic evoked potential mapping in obsessive-compulsive disorder: evidence of frontal lobe dysfunction." Psychiatry Research, vol. 28, no. 1, 1989, pp. 63-71. |
| Nadeau SE, Malloy PF, Andrew ME. "A crossover trial of bromocriptine in the treatment of vascular dementia." Annals of neurology, vol. 24, no. 2, 1988, pp. 270-2. |
| Malloy PF, Webster JS. "Detecting mild brain impairment using the Luria-Nebraska Neuropsychological Battery." Journal of Consulting and Clinical Psychology, vol. 49, no. 5, 1981, pp. 768-70. |
1983-1988 Co-investigator, Environmental treatment of alcohol abusers. (National Institute on Alcohol Abuse and Alcoholism (NIAAA)-AA05827-01A. $677,258).
1983-1988 Co-investigator, Prediction of treatment outcome in alcoholism using neuropsychological tests. (NIAAA-AA06698-01. $38,966).
1985 Co-investigator, Treatment of memory deficits in Korsakoff's patients with guanfacine. (A. H. Robins Pharmaceuticals. $92,750).
1988-1989 Co-investigator, Environmental treatment of alcohol abusers, competitive renewal.(NIAAA-AA06698-04. $137,756).
1989-1992 Co-investigator, Treatment of primary degenerative dementia with nimodopine.(Miles Laboratories. $440,000).
1993-1995 Principal Investigator. Multicenter comparison of placebo and Mentane in outpatients with Alzheimer's disease. (Hoechst Celenase Corp.)
1994-1995 Principal Investigator. Development of a computerized teaching program in neuroimaging. (Wayland Collegium, Brown University... $2500).
1993-1995 Principal Investigator. Quantitative MRI analysis of subcortical white matter changes in late-life onset depression. (Brown University Department of Psychiatry and Human Behavior. $46,000).
1997-1998 Co-investigator. An eight-week, parallel group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. (Pfizer Pharmaceuticals R-0552).
1997-2001 Principal Investigator. Relationship of MRI hyperintensities to treatment response in geriatric depression. (Pfizer Pharmaceuticals R-0552. $50,000).
1997-2002 Co-investigator. Attentional and cognitive training in vital community elderly (ACTIVE). (National Institute on Aging (NIA) 5U101 NR4507-03).
1998-2001 Co-investigator. A multi-center evaluation of the efficacy and safety of donepezil hydrochloride in patients with dementia associated with cerebrovascular disease. (Eisai Inc. E2020-A0001-307).
1998-2000 Principal Investigator. A multicenter evaluation of the efficacy and safety of donepezil hydrochloride (E2020) in subjects with mild cognitive impairment. (Eisai/Pfizer E2020-A001-401).
1999-2004 Co- investigator; PI: R. Cohen. Heart disease, CNS dysfunction, and outcome in the elderly. (National Institutes of Health (NIH)-NIA RO1 1999-PRG-1837)
2000-2001 Co-investigator; PI: D. Cahn-Weiner. Combined Pharmacologic and Behavioral Intervention to Improve Memory in Alzheimer's Disease(Alzheimer's Association).
2000-2001 Co-investigator. Relationship of MRI hyperintensities to treatment response in geriatric depression.(PI: R. Krishnan; Pfizer Pharmaceuticals R-0552).
2000-2002 Co-investigator; M. Aloia, PI. Improving sleep and cognitive functioning in Alzheimer's Disease.(Pfizer Pharmaceuticals, investigator-initiated).
2000-2001 Co-Investigator. A randomized double blind placebo-controlled trial to evaluate the efficacy and safety of galantamine in subjects with mild cognitive impairment (MCI) clinically at risk for development of clinically probable Alzheimer's Disease. (Jannsen Research Foundation GAL-INT-11).
2000-2004 Co-Principal Investigator, Butler site; PI: M. Sano. Alzheimer's disease prevention trial with estrogens. (NIA)
2001-2003 Co-Principal Investigator; Co-PI: Patricia Boyle. Pharmacologic vs. combined pharmacologic-behavioral treatment for apathy in Alzheimer's disease. (Alzheimer's Association, NIRG-01-2686).
2001-2002 Co-investigator. A double-blind, randomized pilot study to evaluate the effects of galantamine and donepezil on sleep and attention and GI tolerance in patients with mild to moderate Alzheimer's disease. (Janssen Research Foundation, GAL-USA-24).
2002-2003 Co-Investigator. A 12-week, double-blind study in patients with mild to moderate Alzheimer's disease who either continue ongoing Donepezil therapy or switch to Galantamine Hydrobromide. (Eisai Inc., E2020-A001-411).
2002-2003 Co-Investigator; PI-John Morris. Cognitive approach to maintaining self-care involvement. (NIA 3 U01 NR04507-0582).
2003 Co-Investigator. A randomized, double-blind, placebo-controlled study of C105 (levo-amphetamine sulfate) to improve memory in patients suffering from anterior communicating aneurysm syndrome. (Sention, Inc. 22013. $22,552).
2003-2004 Co-Investigator. A randomized, double-blind, placebo-controlled study of C105 to improve memory in patients suffering from mild cognitive impairment. (Sention, Inc. 22020. $157,400).
2003 Co-Investigator. A Phase II Double-Blind, Randomized, Dose-Ranging, Placebo-Controlled, Multicenter, Safety and Efficacy Evaluation of Three Doses of NS 2330 in Patients with Mild to Moderate Dementia of the Alzheimer's Type. (Boehringer Ingelheim Pharmaceuticals, Inc #1198.052. $51,020).
2003-2004 Co-Investigator. A 24-week, multi-centered, randomized, double-blind, placebo-controlled evaluation of the efficacy, safety and tolerability of donepezil hydrochloride (E2020) in patients with dementia associated with cerebrovascular disease. (Eisai Medical Research, Inc. # E2020-A001-319. $132,820)
2003-2004 Co-Investigator. An 80-week, randomized, multi-center, parallel-group, double-blind study of the efficacy and safety of atorvastatin 80 mg plus an acetylcholinesterase inhibitor versus an acetylcholinesterase inhibitor alone in the treatment of mild to moderate Alzheimer's disease. (Pfizer, Inc #A2581078. $274,240).
2003-2005 Co-Investigator; PI: S. Correia, Working memory and frontal white matter integrity in mild cognitive impairment. (Alzheimer's Association.).
2003-2008 Principal Investigator. Brown Dementia Research Fellowship. (NIA #T32 AG0200498-01A1. $1,135,000).
2004- Co-Investigator. A 1-year, multicenter, randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of Donepezil Hyudrochloride (E2020) in subjects with mild cognitive impairment. (Eisai # E2020-A001-412).
2004- Co-investigator. Galantamine ER open label rapid dose escalation trial in Alzheimer's disease. (Janssen Pharmaceutica #GAL-ALZ-303. $32,000)
2004- Co-investigator. A double-blind, phase II, safety and efficacy evaluation of ONO-2506PO in patients with mild to moderate Alzheimer's disease.(Ono Pharmaceutical Co. ONO-2506POU010. $214,890).
2004- Co-Investigator. A phase III study of the efficacy and safety of Alzhemed in patients in mild to moderate Alzheimer's disease(Neurochem #CL-758007. $231,000).
2004- Co-Investigator. An open-label eight week investigation of the safety and efficacy of escitalopram for the treatment of anxiety and depression in dementia caregivers.(Forest Laboratories).
2005- Co-investigator; PI: D. Laidlaw. Metrics for qualifying white matter: Image analysis, testing, and application. (Brown intramural Office of Research award. $100,000).
2006- Principal Investigator. Treatment of apathy in Alzheimer's disease with Modafinil. Investigator initiated study. (Cephalon Pharmaceuticals. $40,000).2006- 2011 Advisory Board, Development of a neuropsychological battery to measure executive dysfunction. (NINDS 05-02, Joel Kramer, PI).
2008- 2009 Co-investigator. A Phase 2 multicenter, randomized, double-blind, placebo-controlled study of the safety, tolerability, and pharmacokinetics of multiple intravenouse doses of PF-04360365 in patients with mild to moderate Alzheimer’s disease. (Pfizer A9951002).
2008- 2010 Co-investigator. A Phase III multicenter, randomized, double-blind, placebo-controlled parallel group, efficacy and safety trial of Bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer’s disease who are apolipoprotein E e4 carriers. (Elan 115727).
2008- 2010 Co-investigator. A Phase III multicenter, randomized, double-blind, placebo-controlled parallel group, efficacy and safety trial of Bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer’s disease who are apolipoprotein E e4 non-carriers. (Elan 115727).
2008- 2010 Co-investigator. A randomized, double-blind, placebo-controlled, dose-ranging, safety and efficacy study of oral ELND005 (AZD-103) in Alzheimer’s disease. (Elan D005-AD201).
2009- 2012 Principal investigator. CONCERT: A phase-3 multicenter, randomized, placebo-controlled double blind study of Dimebon in patients with mild-to-moderate Alzheimer’s disease on donepezil. (Medivation DIM18).
2007- Co-investigator. Alzheimer Disease Neuroimaging Initiative (ADNI, ADNI-GO, ADNI-2). (National Institute of Aging; Mark Weiner, PI).
2010- Co-investigator. Imaging Myelin Loss Associated with Alzheimer's Disease. (Alzheimer's Association; Sean Deoni, PI).
2012- Co-investigator. A randomized, double-blind, placebo-controlled multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of BIIB037 in subjects with prodromal or mild Alzheimer’s disease. (Biogen 221AD103).
2012- Co-principal investigator. Amyloid imaging in normal pressure hydrocephalus. (AVID 14-A18).
2012- Co-investigator. A 12-month double blind, randomized, controlled feasibility study to evaluate the safety, efficacy and tolerability of deep brain stimulation of the fornix (DBS-f) in patients with mild probable Alzheimer’s disease. (ADVANCE; Functional Neuromodulation DBS-FNMI-001)
Malloy, P.F., Correia, S., Stebbins, G., & Laidlaw, D. (2007). Neuroimaging of white matter in aging and dementia. The Clinical Neuropsychologist, 21, 1-38.
Malloy, P.F., Tremont, G., Grace, J., & Frakey, L. (2007). The Frontal Systems Behavior Scale (FrSBe) discriminates frontotemporal dementia from Alzheimer's disease. Alzheimer’s & Dementia 3, 200–203
Malloy, P.F. & Grace, J. (2005). A review of rating scales for measuring behavior change due to frontal systems damage. Cognitive and Behavioral Neurology, 18, 18-27.
Grace, J. & Malloy, P.F. (2002). The Frontal Systems Behavior Scale (FrSBe). Psychological Assessment Resources, Odessa, FL.
Salloway S, Malloy P, Duffy J. (2001). The frontal lobes and neuropsychiatric illness. American Psychiatric Press Inc., Washington, D.C.
Malloy, P.F., & Aloia, M. (1998). Frontal lobe dysfunction in traumatic brain injury. Seminars in Clinical Neuropsychiatry, 3, 186-194.
Malloy, P.F. & Duffy, J. (1994). The frontal lobes in neuropsychiatric disorder. In F. Boller & J. Grafman (Eds.), Handbook of Neuropsychology (Vol. 9), 203-232.
Malloy, P.F. & Richardson, E.D. (1994). The frontal lobes and content-specific delusions. Journal of Neuropsychiatry and Clinical Neuroscience, 6, 455-466.
Malloy, P. F., Rasmussen, S., Braden, W. and Haier, R. (1989). Topographic evoked potential mapping in obsessive-compulsive disorder: Evidence of frontal lobe dysfunction. Psychiatry Research, 28, 63-71.
| Year | Degree | Institution |
|---|---|---|
| 1981 | PhD | State University of New York at Binghamton |
| 1980 | MA | State University of New York at Binghamton |
| 1972 | BA | Dartmouth College |
1995 Outstanding Teaching Award in Psychology, DPHB, Brown Medical School
1995 Fellow, National Academy of Neuropsychology
2002 Fellow, American Neuropsychiatric Association
2002 Dean's Teaching Excellence Award, Brown Medical School
2002 Dean's Teaching Excellence Award, Brown Medical School
2010 Exemplary Teaching Certificate in Brain Sciences, Brown Medical School
2012 Exemplary Teaching Certificate in Brain Sciences, Brown Medical School
2015 Exemplary Teaching Certificate in Brain Sciences, Brown Medical School
2015 Caldwell Award for Excellence in Teaching, DPHB, Brown Medical School
| Name | Title |
|---|---|
| Correia, Stephen | Associate Professor of Psychiatry and Human Behavior |
| Grace, Janet | Professor Emerita of Psychiatry and Human Behavior |
| Greenberg, Benjamin | Professor of Psychiatry and Human Behavior |
| Klinge, Petra | Professor of Neurosurgery |
| McLaughlin, Nicole | Associate Professor of Psychiatry and Human Behavior |
| Piryatinsky, Irene | Assistant Professor of Psychiatry and Human Behavior, Clinician Educator |
| Rasmussen, Steven | Professor of Psychiatry and Human Behavior |
| Salloway, Stephen | Professor of Psychiatry and Human Behavior, Professor of Neurology |
| Tremont, Geoffrey | Professor Emeritus of Psychiatry and Human Behavior |
| Psychologist | State of RI | 1983-2020 |
2003-2008 Director, Brown Dementia Research Fellowship. A NIA-supported T32 program designed to train dementia researchers. The program involves faculty from four hospitals and six Brown departments.
2001-2010 Associate Director, Brown University Psychology Training Consortium. Responsible for supervision of the postdoctoral research training portion of the Consortium, which involves over 30 trainees per year in T32 and F32 supported positions.
1984 - 2001 Neuropsychology Track Coordinator. Coordinated and developed this track of the Brown University Psychology Consortium from its inception. Responsible for administration of training of all neuropsychology students, organization of seminars for the track, and establishment of community/research placements.
1984-2019 Neuropsychology Rotation Supervisor. Supervise Butler Hospital rotation for a full-time intern in the neuropsychology track of the Psychology Internship Consortium.
1987-2019 Neuropsychology Post-doctoral Fellowship Supervisor. Provide supervision for one to two full-time post-doctoral fellow in the neuropsychology track of the Psychology Training Consortium, conducting clinical and research activities at Butler.
1988-2010 Brown Alcohol & Addictions Center Faculty Member.
Teach seminar sequence on neuropsychological impairment in alcohol for post-doctoral fellows of the Center. Act as mentor for research activities of fellows.
1984-2019 Neuropsychology Internship & Fellowship Seminars
Neuroimaging
Neuropsychiatric disorders
Frontal lobe disorders
Neuropsychology of substance abuse
1990-2019 Psychiatry Resident PGY-3 Seminars
Neuropsychiatry: Neuropsychological assessment
Neuropsychiatry: Frontal lobe syndromes
Neuropsychiatry: Sequelae of alcohol abuse
Forensics: Detecting malingering and exaggeration
1990-2019 Psychiatry Resident PGY-4 Seminars
Introduction to neuropsychological testing
1998- 2019 Geriatric Psychiatry Fellowship Seminar
Age-associated memory impairment
Neuropsychological assessment in the elderly
Psychotic disorders in the elderly
1998-2019 Biomed 370-The Human Brain and Behavior
Frontal lobe function and dysfunction
Memory systems and memory disorders
